At Pine Point Medical , patients frequently ask how semaglutide compares to tirzepatide, especially when considering long-term weight loss goals, appetite regulation, and side effect management
Oxyntomodulin Inhibits Food Intake in the Rat
Clinical trial data for prescription GLP-1 medications shows average body weight reduction of 15-20 percent over 68 weeks in controlled studies
Decotiis recommends opting for newer medications, rather than older, less popular varieties
however, it is just starting to poke its head out to the media
in my opinion, this is likely random variation given the lack of effect on the primary endpoint and on time-to-worsening CDR (although some are wondering whether a longer trial might be necessary to unveil a true signal)